1. Home
  2. NPKI vs CDMO Comparison

NPKI vs CDMO Comparison

Compare NPKI & CDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NPKI
  • CDMO
  • Stock Information
  • Founded
  • NPKI 1932
  • CDMO 1981
  • Country
  • NPKI United States
  • CDMO United States
  • Employees
  • NPKI N/A
  • CDMO N/A
  • Industry
  • NPKI Metal Fabrications
  • CDMO Biotechnology: Pharmaceutical Preparations
  • Sector
  • NPKI Industrials
  • CDMO Health Care
  • Exchange
  • NPKI Nasdaq
  • CDMO Nasdaq
  • Market Cap
  • NPKI 621.1M
  • CDMO 793.8M
  • IPO Year
  • NPKI N/A
  • CDMO N/A
  • Fundamental
  • Price
  • NPKI $7.01
  • CDMO $12.49
  • Analyst Decision
  • NPKI
  • CDMO Hold
  • Analyst Count
  • NPKI 0
  • CDMO 3
  • Target Price
  • NPKI N/A
  • CDMO $12.25
  • AVG Volume (30 Days)
  • NPKI 385.2K
  • CDMO 1.3M
  • Earning Date
  • NPKI 02-19-2025
  • CDMO 12-10-2024
  • Dividend Yield
  • NPKI N/A
  • CDMO N/A
  • EPS Growth
  • NPKI N/A
  • CDMO N/A
  • EPS
  • NPKI N/A
  • CDMO N/A
  • Revenue
  • NPKI $748,372,000.00
  • CDMO $150,445,000.00
  • Revenue This Year
  • NPKI N/A
  • CDMO $19.04
  • Revenue Next Year
  • NPKI N/A
  • CDMO $20.87
  • P/E Ratio
  • NPKI N/A
  • CDMO N/A
  • Revenue Growth
  • NPKI 93.70
  • CDMO 6.75
  • 52 Week Low
  • NPKI $5.61
  • CDMO $5.90
  • 52 Week High
  • NPKI $8.65
  • CDMO $12.51
  • Technical
  • Relative Strength Index (RSI)
  • NPKI N/A
  • CDMO 65.47
  • Support Level
  • NPKI N/A
  • CDMO $12.41
  • Resistance Level
  • NPKI N/A
  • CDMO $12.50
  • Average True Range (ATR)
  • NPKI 0.00
  • CDMO 0.04
  • MACD
  • NPKI 0.00
  • CDMO -0.01
  • Stochastic Oscillator
  • NPKI 0.00
  • CDMO 84.62

About NPKI NPK International Inc. Common Stock

NPK International Inc Formerly Newpark Resources Inc is a diversified supplier providing environmentally-sensitive products, as well as rentals and services to customers across multiple industries. The company has two operating segments: Industrial Solutions and Fluids Systems. Fluids Systems segment which generates the majority of the revenue, provides drilling, completion, and stimulation fluids products and related technical services to customers for oil, natural gas, and geothermal projects. Geographically, the company derives majority of its revenue from the United States and also has its presence in Canada, EMEA, Latin America, and Asia Pacific regions.

About CDMO Avid Bioservices Inc.

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.

Share on Social Networks: